Zhili Xin

This inventor holds 44 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 16 EPO patents, primarily in O-Glycoprotein Inhibitors. Top assignees: Biogen Ma Inc., Abbott Laboratories Corporation, Mcgill University. Active years: 1998-2026.

USPTO Granted Patents = 44 (Patent Applications = 16)

% Patents Active = 72.7

CIPO Patents = 2 (Patent Applications = 15)

EPO Patents = 16 (Patent Applications = 41)

Average Co-Inventor Count = 6.4

ph-index = 9

Forward Citations = 300(Granted Patents)

Location History:

Montreal, CA (1998 - 2003)
Gurnee, IL (US) (2000 - 2005)
Lake Bluff, IL (US) (2005 - 2013)
Cambridge, MA (US) (2017 - 2022)
Lexington, MA (US) (2011 - 2024)

Company Filing History:

Abbott Laboratories Corporation

Millennium Pharmaceuticals Limited

patents

5. 4 out of 63

Sunesis Pharmaceuticals, Inc.

Isis Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

O-Glycoprotein Inhibitors

ASK1 Inhibitors

Raf Kinase Inhibitors

S1P Modulating Agents

Diacylglycerol O-Acyltransferase

NRF2 Activator

Thienopyridones

Cell Adhesion Compounds

Phosphorothioate Oligomers

Bicyclic Ether

Spirocyclic

Azetidinyl

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12565504 - Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors (2026-03-03),

2. 12522595 - Bicyclic ether O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors (2026-01-13),

3. 12421224 - Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors (2025-09-23),

4. 12404263 - ASK1 inhibiting agents (2025-09-02),

5. 12319679 - Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors (2025-06-03),

6. 12275728 - O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors (2025-04-14),

7. 12180205 - O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors (2024-12-31),

8. 11999715 - ASK1 inhibiting agents (2024-06-04),

9. 11814362 - ASK1 inhibiting agents (2023-11-14),

10. 11459324 - O-glycoprotein-2-acetamido-2-deoxy-3-D-glycopyranosidase inhibitors (2022-10-04),

11. 10968181 - NRF2 activator (2021-04-06),

12. 10273234 - Compounds that are S1P modulating agents and/or ATX modulating agents (2019-04-30),

13. 10144732 - ATX modulating agents (2018-12-04),

14. 10017506 - ATX modulating agents (2018-07-10),

15. 9944666 - Compounds that are S1P modulating agents and/or ATX modulating agents (2018-04-17),

Title: Zhili Xin: Pioneering Inventor from Lexington

Introduction: Zhili Xin is a trailblazing inventor based in Lexington, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Zhili Xin holds several patents in the areas of biotechnology, renewable energy, and artificial intelligence, showcasing her diverse range of expertise.

Career Highlights: With over two decades of experience in research and development, Zhili Xin has worked for leading tech companies and research institutions, consistently pushing the boundaries of innovation.

Collaborations: Throughout her career, Zhili Xin has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge exchange.

Conclusion: Zhili Xin's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and researchers worldwide.